scispace - formally typeset
R

Roman G. Timoshchenko

Researcher at University of North Carolina at Chapel Hill

Publications -  10
Citations -  181

Roman G. Timoshchenko is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: G protein-coupled receptor kinase & Chemokine receptor. The author has an hindex of 6, co-authored 9 publications receiving 147 citations.

Papers
More filters
Journal ArticleDOI

G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.

TL;DR: It is demonstrated that alterations inGRK3 expression levels in tumor cells directly affect migration and invasion in vitro and the establishment of distant metastasis in vivo, and that GRK3 dysregulation may play an important part in TNBC metastasis.
Journal ArticleDOI

Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.

TL;DR: The findings indicate that CX(3) CR1 deficiency is protective in inflammatory arthritis and may have effects that extend beyond migration that involve adaptive immune responses in autoimmune disease.
Journal ArticleDOI

G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses

TL;DR: It is concluded that the loss of GRK3‐mediated regulation of CXCL12/CXCR4 signaling contributes to some, but not all, of the complete WHIM phenotype and thatGRK3 inhibition may be beneficial in the treatment of inflammatory arthritis.
Journal ArticleDOI

G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis.

TL;DR: The results suggest that GPSM3 is an important regulator of monocyte function involving mechanisms of differentiation, survival, and chemotaxis, and deficiency in GPSM 3 expression is protective in acute inflammatory arthritis.
Journal ArticleDOI

Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer

TL;DR: The authors showed the important role the immune system played and would enable better designs of future drug delivery systems and emphasize that the interplay between PLD and chemokines may have an important role in optimizing PLD therapy.